Skip to content
ABOUT
MANAGEMENT TEAM
ADVISORY BOARD
OUR PARTNERS
TECHNOLOGY
TCR THERAPY
iSORT PLATFORM
PIPELINE
ANTIBODIES
NEWS
CONTACT
CAREERS
ABOUT
MANAGEMENT TEAM
ADVISORY BOARD
OUR PARTNERS
TECHNOLOGY
TCR THERAPY
iSORT PLATFORM
PIPELINE
ANTIBODIES
NEWS
CONTACT
CAREERS
ABOUT
MANAGEMENT TEAM
ADVISORY BOARD
OUR PARTNERS
TECHNOLOGY
TCR THERAPY
iSORT PLATFORM
PIPELINE
ANTIBODIES
NEWS
CONTACT
CAREERS
Loading...
Redefining T Cell Immunotherapy
Reprogramming tumors in vivo to resemble transplanted organs, activating allogeneic T cells against them. Off-the-shelf, with no ex vivo expansion.
Learn About TCR
View Our Pipeline
Home
Site Admin
2020-06-13T16:42:43+00:00
Page load link
Go to Top